The ACCP “Excellence in Achievement” Program is pleased to recognize Ammar Raza, MBBS, MBA, FCP, D.Diab, PGD, E&D, Regional Medical Director- Middle East & Africa and Area Medical Lead (EMEA)- HaCa, Allergan Aesthetics an AbbVie Co in Dubai, United Arab Emirates. Dr. Raza joined ACCP in 2013 as a Member and became a Fellow in 2018. He is currently an active member of the Publications Committee and was on the Education Committee from 2018 to 2020. During the 2020 ACCP Annual Meeting, Dr. Raza served as an Abstract Reviewer.
Dr. Raza specializes in clinical diabetology/endocrinology and management. He graduated from the Indian Inst of Management Bangalore and has over two decades in healthcare management. Dr. Raza also served as an honorary visiting faculty to the National Inst of Pharmaceutical Education & Research in Hyderabad, India. As a medical/clinical leader in biopharmaceutical emerging markets in Asia, Latin America, Russia/CIS, Middle East and Africa, he has experience in medical affairs, clinical development (Phase 1 - 4 & NIS/RWE) and pharmacovigilance for innovative small molecules, biologics, vaccines, biosimilars, medical devices and branded generics across multiple therapeutic areas. In addition to his activities in ACCP, in 2019 Dr. Raza served on the program committee for the Drug Information Association (DIA) India's first program on new paradigms in translational research & early development. He also served on the Organization of Pharmaceutical Producers of India's medical and regulatory committee and vaccines committee. Additionally, Dr. Raza has been an invited speaker to multiple national and international conferences and has co-authored and authored scientific publications in peer-reviewed journals. He has been the recipient of many academic & industry awards to include but not limited to the Int'l Association of Research & Development Organization Award for "Contribution in Medical Science-2018" and the 2021 R&D Presidents Award presented by Allergan Aesthetics, an AbbVie Co.
Dr. Raza kindly shared his thoughts on what ACCP membership means to him:
“Membership in ACCP provides a way to learn as well as contribute to the pharmacology community. I believe this fits in well with my motto of ‘making a meaningful difference to people’s lives by exploring science and applying technology to bring the best therapies for patients. In the process of being an ACCP Member I can touch many people, like colleagues from both academia and industry, budding pharmacologists and the wider society, all working for similar goals and objectives.”
Congratulations, Dr. Raza, on being recognized for your outstanding achievements and contributions to ACCP!